Keywords: Recordati, First-quarter 2011 finaincial results, Lercandipine, Pitavastatin, Spain

Recordati 1st-qtr 2011 sales up 6.4%, despite generic lercandipine, pivastatin debut

Article | 10 May 2011

Print This

Italian drugmaker Recordati SpA (REC: MI) has presented results for the first quarter of 2011 and its updated 2011-2013 Business Plan, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in